Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Net Margin (2016 - 2025)

Nephros (NEPH) has 16 years of Net Margin data on record, last reported at 7.07% in Q3 2025.

  • For Q3 2025, Net Margin rose 187.0% year-over-year to 7.07%; the TTM value through Sep 2025 reached 8.51%, up 1547.0%, while the annual FY2024 figure was 0.52%, 1158.0% up from the prior year.
  • Net Margin reached 7.07% in Q3 2025 per NEPH's latest filing, up from 5.57% in the prior quarter.
  • Across five years, Net Margin topped out at 11.87% in Q1 2025 and bottomed at 134.12% in Q3 2022.
  • Average Net Margin over 5 years is 25.84%, with a median of 12.21% recorded in 2023.
  • Peak YoY movement for Net Margin: tumbled -8672bps in 2022, then surged 12926bps in 2023.
  • A 5-year view of Net Margin shows it stood at 42.79% in 2021, then rose by 16bps to 35.89% in 2022, then surged by 44bps to 20.1% in 2023, then surged by 147bps to 9.41% in 2024, then dropped by -25bps to 7.07% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 7.07% in Q3 2025, 5.57% in Q2 2025, and 11.87% in Q1 2025.